JACQUELYNN WITNAUER: Open Payments
NPI 1285096321 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 33 payments from 16 companies in 2025. Trend: 2023 $688 · 2024 $712 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $129 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Kestra Medical Technology Services, Inc. | 3 | $51 |
| Amgen Inc. | 3 | $49 |
| Corcept Therapeutics | 3 | $46 |
| Esperion Therapeutics, Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
Products named: LEQVIO, Kerendia, VERQUVO, Assure WCD, REPATHA, Korlym, NEXLETOL, CAMZYOS.
Industry payments across FL — which companies pay providers there.
